Adding a medicine to improve healing of complicated skin sores
Part of Infections, Skin clinical trials.
This study tests whether adding a special medicine (an antimicrobial adjuvant) to the standard treatment for complicated skin sores caused by leishmaniasis can improve healing. It is for people in Ethiopia with sores that are large, many, or in sensitive areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a skin lesion that needs whole-body treatment, such as a large sore (over 4 cm), more than 4 sores, sores on joints or fingers, or sores near your eyes, nose, or lips.
- You need at least one sore that is open, crusted, or scaly, and can be clearly separated from other sores by at least half a centimeter.
- You must be over 4 years old.
- You must be willing to stay in the hospital for 4 weeks for treatment and monitoring.
- You must not have received any leishmaniasis treatment (like injections, creams, or heat/cold therapy) or antibiotics in the past month.
- You must not be pregnant or breastfeeding, and you must not have serious heart, kidney, or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether arnica tincture (a plant extract) can treat cutaneous leishmaniasis, an infection causing skin ulcers. It compares arnica to a standard injected treatment and looks at how well each works and how safe they are.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This study compares different drugs to find the best one for treating cutaneous leishmaniasis, a skin infection that causes sores. You might get one of several treatments, and the goal is to see which works best and is safest for patients like you.
This trial tests whether adding a special laser treatment (fractional CO₂ laser) to the standard injected medicine (Glucantime) helps heal skin sores from a parasite infection better than the medicine alone. It may offer a more effective way to clear the sores and improve healing.
This study tests whether applying a heat pack to skin sores caused by cutaneous leishmaniasis can help treat them. It's for people who cannot take the standard medication or prefer a non-drug option.
This study tests a gel containing miltefosine (a medicine) applied directly to the skin sores caused by cutaneous leishmaniasis. The goal is to see if the gel is safe and works to clear the sores.
Hear when a new Leishmaniasis, Cutaneous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.